Zanubrutinib 80 MG ( DrugBank: Zanubrutinib )

1 disease

ID	Disease name (Link within this page)	Number of trials
300	IgG4-related disease	1

300. IgG4-related disease

Clinical trials : 36 / Drugs : 49 - (DrugBank : 22) / Drug target genes : 16 - Drug target pathways : 98

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04602598 (ClinicalTrials.gov)	January 15, 2022	20/10/2020	Zanubrutinib in Patients With IgG4-Related Disease	A Phase II, Single-Site, Open-Label Study of Zanubrutinib in Patients With IgG4-Related Disease	IgG4 Related Disease	Drug: Zanubrutinib 80 MG	Matthew C. Baker	Stanford University	Not yet recruiting	18 Years	85 Years	All	10	Phase 2	United States

First Previous1Next Last